- SEK2.01bn
- SEK1.43bn
Brief: Flerie Portfolio Firm Reports Positive Bladder Cancer Data
Brief: Flerie Completes Bonus Issue
Brief: Flerie Majority Owner Waives Share Allocation
Brief: Flerie To Redeem All Outstanding Series C Shares
Brief: Flerie Q1 Net Result At SEK -61 Million
Brief: Flerie, Lipum Merger Plan Approved
Brief: Flerie's Lipum Selected For EUR 8 Million Horizon Europe Grant
Brief: Flerie Decides On SEK 76 Mln Directed Share Issue
Brief: Microbiotica Reports Positive Phase 1B Data For MB310
Brief: Flerie's Portfolio Company Nanologica Acquires Syntagon
Brief: Flerie Proposes No Dividend Be Paid For 2025
Brief: Flerie’s Portfolio Company Chromafora Buys Montrose Environmental Group Denmark
Brief: Kahr Bio Secures $22 Mln In Equity Funding
Brief: Flerie To Issue 3,755,920 New Ordinary Shares As Merger Consideration
Brief: Flerie Receives Approval For Merger With Lipum
Brief: Flerie To Divest Holdings In Limited Partnership Segment
Brief: Flerie, Lipum Have Agreed On Merger Plan
Brief: Flerie's Xintela's XSTEM Shows Safety And Efficacy 24 Months Post-Treatment
Brief: Swedish Companies Registration Office Permits Implementation of Flerie, Toleranzia's M&A